Regulation of NMDA receptor trafficking by amyloid-β
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta-dependent endocytosis of NMDA receptors required the alpha-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This synaptotoxicity is associated with a reduction in the surface expression of various receptor proteins, including those forming the N-methyl-D-aspartate receptors [26,27], which are critical for generation of long-term potentiation in hippocampal synapses.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“Oligomeric Aβ species have been shown to cause memory deficits in rodents [25] and are known for their synaptotoxic properties.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“It has been previously reported that extracellular application of Ab oligomers to primary neuronal cultures or organotypic hippocampal slices induce rapid changes in the structure and density of synaptic spines 47,48 and reduces expression of NMDARs and related synaptic proteins, 49 through several signaling pathways, one of which involves the a-7 nicotinic receptor.49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“Indeed Aβ production and amyloid production has been shown to reduce cell surface levels of other proteins including the NMDA receptor and the EphB2 receptor, both involved in synaptic plasticity [57], [58].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [57]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Results Amyloid-β decreases surface expression of NMDA receptors Low amounts of secreted soluble amyloid-β regulate glutamatergic currents mediated by both NMDA and AMPA receptors without affecting GABA receptor current”
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Cited by
Items 701–800 of 1,006
Neuroprotective Role of a Brain-Enriched Tyrosine Phosphatase, STEP, in Focal Cerebral Ischemia
Deb, I., Manhas, N., Poddar, R., Rajagopal, S., Allan, A. M., Lombroso, P. J., Rosenberg, G. A., Candelario‐Jalil, E., & Paul, S. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2346-12.2013 · Cited by 49
“Using a phosphospecific antibody that recognizes STEP only when it is phosphorylated at the PKA site in the KIM domain (Paul et al., 2003; Snyder et al., 2005; Valjent et al., 2005), we further confirmed that STEP61 is basally phosphorylated at this site (Fig.”
BackgroundSelf-citationNavarro, A. I., & Mandyam, C. D. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.043 · Cited by 49
“The phosphorylation of Tyr-1472 by Fyn kinase disrupts the interaction between NMDARs and the adaptor protein-2 complex, ultimately preventing the clathrin-mediated endocytotic pathway and stabilizing the receptor (Lavezzari et al., 2003; Prybylowski et al., 2005); whereas, dephosphorylation of NMDARs at Tyr-1472 prom…”
InfluentialEph receptors: New players in Alzheimer's disease pathogenesis
Cissé, M., & Checler, F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.028 · Cited by 46
“For instance, Aβ reduced NMDAR subunit NR1 in neuronal cell culture and in hAPP transgenic mice via the activation of α-7 nicotinic receptor and the tyrosine phosphatase STEP (Striatal-enriched protein tyrosine phosphatase) (Snyder et al., 2005).”
The Role of Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Cognition
Fitzpatrick, C. J., & Lombroso, P. J. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00047 · Cited by 55
Self-citationCarnosine Protects Against Aβ42-induced Neurotoxicity in Differentiated Rat PC12 Cells
Fu, Q., Dai, H., Hu, W., Fan, Y., Shen, Y., Zhang, W., & Chen, Z. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9235-0 · Cited by 50
“Regulation of NMDA Receptor Trafficking by Carnosine Since Ab promotes endocytosis of NMDA receptors without affecting trafficking of GABAAtype receptors (Snyder et al. 2005), we further determined whether the modulation of traf- ficking of NMDA receptors is involved in this protection by carnosine.”
Tyrosine dephosphorylation is required for Bak activation in apoptosis
Fox, J. L., Ismail, F., Azad, A. K., Ternette, N., Leverrier, S., Edelmann, M. J., Kessler, B. M., Leigh, I. M., Jackson, S., & Storey, A. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.244 · Cited by 54
“…abolish phosphatase activity (Snyder et al, 2005), together with a second mutation in the kinase interaction motif (KIM), which is involved in PTPN5 regulation (S245A; Paul et al, 2000; Snyder et al, 2005), were transiently overexpressed in HCT116 cells expressing WT Bak (Supplementary Figure 16).”
Tillement, L., Lecanu, L., Yao, W., Greeson, J., & Papadopoulos, V. (2006) · Steroids · doi:10.1016/j.steroids.2006.05.003 · Cited by 52
MMP‐7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function
Szklarczyk, A., Ewaleifoh, O., Beique, J., Wang, Y., Knorr, D., Haughey, N., Malpica, T., Mattson, M. P., Huganir, R., & Conant, K. (2008) · The FASEB Journal · doi:10.1096/fj.07-101402 · Cited by 47
“Nor was this loss diminished by pretreatment of cultures with cyclosporine A (CsA), an inhibitor of the calcium-activated phosphatase calcineurin, which may play a role in loss of surface subunit expression (38).”
β-Amyloid Peptide: the Cell Compartment Multi-faceted Interaction in Alzheimer’s Disease
Picone, P., Nuzzo, D., Giacomazza, D., & Carlo, M. D. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00116-9 · Cited by 54
Increased Aβ Production Leads to Intracellular Accumulation of Aβ in Flotillin-1-Positive Endosomes
Rajendran, L., Knobloch, M., Geiger, K. D., Dienel, S., Nitsch, R., Simons, K., & Konietzko, U. (2007) · Neurodegenerative Diseases · doi:10.1159/000101841 · Cited by 47
The Role of Ephs and Ephrins in Memory Formation
Dines, M., & Lamprecht, R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv106 · Cited by 47
“Moreover, Aβ reduced NMDAR subunit NR1 in neuronal cell culture and hAPP transgenic mice (Snyder et al., 2005).”
Puri, V., Wang, X., Vardigan, J. D., Kuduk, S. D., & Uslaner, J. M. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.029 · Cited by 48
MAPK-specific tyrosine phosphatases: new targets for drug discovery?
Barr, A., & Knapp, S. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.08.005 · Cited by 50
George, J., Baden, D. G., Gerwick, W. H., & Murray, T. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212584109 · Cited by 53
“Trafficking and surface expression of NMDARs are also regulated by neuronal activity (38) and phosphorylation of the GluN2B subunit (39).”
BackgroundAhmed, M. M., Dhanasekaran, A. R., Block, A., Tong, S., Costa, A. C. S., Stasko, M. R., & Gardiner, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119491 · Cited by 51
Pousinha, P. A., Mouska, X., Raymond, E., Gwizdek, C., Dhib, G., Poupon, G., Zaragosi, L., Giudici, C., Bethus, I., Pacary, E., et al. (2017) · eLife · doi:10.7554/elife.25659 · Cited by 51
“These opposite effects may be due to concomitant generation of Ab, which was shown to decrease synaptic NMDARs in cultured neurons (Snyder et al., 2005).”
Alzheimer’s Disease Model System Using Drosophila
Tsuda, L., & Lim, Y. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0529-0_3 · Cited by 50
Wang, Z., Zheng, P., Xie, Y., Chen, X., Solowij, N., Green, K., Chew, Y. L., & Huang, X. (2021) · The FASEB Journal · doi:10.1096/fj.202002724r · Cited by 58
Alzheimers Disease - An Interactive Perspective
Heese, K., & Akatsu, H. (2006) · Current Alzheimer Research · doi:10.2174/156720506776383022 · Cited by 50
“[67] Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al.”
BackgroundKatsuki, F., Gerashchenko, D., & Brown, R. E. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.07.002 · Cited by 52
The Role of Reelin Signaling in Alzheimer’s Disease
Yu, N., Tan, M., Yu, J., Xie, A., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9459-9 · Cited by 51
Jang, S.-S., Royston, S. E., Xu, J., Cavaretta, J. P., Vest, M. O., Lee, K. Y., Lee, S., Jeong, H. G., Lombroso, P. J., & Chung, H. J. (2015) · Molecular Brain · doi:10.1186/s13041-015-0148-4 · Cited by 45
“STEP61-dependent manner STEP61 dephosphorylates the NMDAR subunit GluN2B at Tyr(1472) [5, 6] and reduces Tyr-phosphorylation of the AMPAR subunit GluA2 following group 1 metabotropic glutamate receptor (mGluR) stimulation [3].”
Self-citationOhtake, N., Saito, M., Eto, M., & Seki, K. (2014) · Regulatory Peptides · doi:10.1016/j.regpep.2014.04.003 · Cited by 52
Isono, T., Yamashita, N., Obara, M., Araki, T., Nakamura, F., Kamiya, Y., Alkam, T., Nitta, A., Nabeshima, T., Mikoshiba, K., et al. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.08.005 · Cited by 52
“Interestingly, recent findings suggest that A oligomers can cause internalization of NMDA receptor, and a switch in its composition (Snyder et al., 2005; Palop and Mucke, 2010; Kessels et al., 2013).”
BackgroundAri, C., Borysov, S. I., Wu, J., Padmanabhan, J., & Potter, H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.006 · Cited by 49
“Ab inhibition of Eg5 and/or kinesin 5 may also explain several previous observations that localization and function of various neurotransmitter receptors and other membrane proteins, including the NMDA receptor and the APP and PS proteins themselves, are disrupted in AD (Almeida et al., 2005; Honda et al., 2000; Li et…”
BackgroundLee, H., Rao, J. S., Chang, L., Rapoport, S. I., & Bazinet, R. P. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700406-jlr200 · Cited by 47
“eral brain disorders (3), including Alzheimer’s disease (4, 5), schizophrenia (6, 7), major depression (8), and bipolar”
Francis, P. T., Parsons, C. G., & Jones, R. W. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.124 · Cited by 45
Oxytocin reverses Aβ-induced impairment of hippocampal synaptic plasticity in mice
Takahashi, J., Yamada, D., Ueta, Y., Iwai, T., Koga, E., Tanabe, M., Oka, J., & Saitoh, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.046 · Cited by 54
Isoprenoids and Related Pharmacological Interventions: Potential Application in Alzheimer’s Disease
Li, L., Zhang, W., Cheng, S., Cao, D., & Parent, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8253-1 · Cited by 45
Francis, P. T. (2008) · Neurodegenerative Diseases · doi:10.1159/000113713 · Cited by 46
Steele, J., Brautigam, H., Short, J. A., Sowa, A., Shi, M., Yadav, A., Weaver, C. M., Westaway, D. A., Fraser, P. E., George‐Hyslop, P. S., et al. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23536 · Cited by 47
Bennett, B. M., Reynolds, J. N., Prusky, G. T., Douglas, R. M., Sutherland, R. J., & Thatcher, G. R. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301054 · Cited by 53
“A further study provided a pathway for Ab-induced disruption of NO/cGMP signaling initiated by binding of Ab to the a7 nicotinic ACh receptor (Snyder et al, 2005).”
Yang, W., Ma, K., Chen, X. L., Shi, L., Bu, G., Hu, X. D., Han, H., Liu, Y., & Qian, Y. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.08.013 · Cited by 49
The Role of β-Amyloid Protein in Synaptic Function: Implications for Alzheimers Disease Therapy
Peña‐Ortega, F., Gutiérrez-Lerma, A. I., Quiroz‐Baez, R., & Arias, C. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359531 · Cited by 56
Sun, G. Y., He, Y., Chuang, D. Y., Lee, J. C., Gu, Z., Simonyi, Á., & Sun, A. Y. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8261-1 · Cited by 49
“In neurons, toxic Aβ oligomers have been shown to downregulate NMDA receptor trafficking [5], alter neuronal circuitry, and impair synaptic activity [6].”
Amyloidosis in Retinal Neurodegenerative Diseases
Masuzzo, A., Dinet, V., Cavanagh, C., Mascarelli, F., & Krantic, S. M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00127 · Cited by 50
“A decrease in NMDA receptors by Aβ involves a similar mechanism via dephosphorylation of the NR2B subunit and subsequent increase in receptor endocytosis (73).”
Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease
Nayeri, T., Sarvi, S., Sharif, M., & Daryani, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07151 · Cited by 47
Association between Sleep, Alzheimer’s, and Parkinson’s Disease
Matsumoto, S., & Tsunematsu, T. (2021) · Biology · doi:10.3390/biology10111127 · Cited by 47
Xu, L., Zhou, Y., Hu, L., Jiang, H., Dong, Y.-B., Shen, H., Lou, Z., Yang, S., Ji, Y., Ruan, L., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.772980 · Cited by 46
Paradoxical Facilitatory Effect of Low-Dose Alcohol Consumption on Memory Mediated by NMDA Receptors
Kalev‐Zylinska, M. L., & During, M. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2789-07.2007 · Cited by 46
“Expression of NMDARs declines with age and in Alzheimer’s disease (Snyder et al., 2005), and moderate drinking reduces the risk of age-related dementias.”
Calcineurin contributes to spatial memory impairment induced by rapid eye movement sleep deprivation
Wang, G.-P., Huang, L., Wu, H., Zhang, L., You, Z.-D., & Zhao, Z. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832f0772 · Cited by 48
Liu, W., Li, Y., Zhao, T., Gong, M., Wang, X., Zhang, Y., Xu, L., Li, W., Li, Y., & Jia, J. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102534 · Cited by 46
Bergmans, B. A., Shariati, S. A., Habets, R. L. P., Verstreken, P., Schoonjans, L., Müller, U., Dotti, C. G., & Strooper, B. D. (2010) · Stem Cells · doi:10.1002/stem.296 · Cited by 50
Aging of the Nmda Receptor: From A Mouse‘s Point of View
Magnusson, K. R. (2012) · Future Neurology · doi:10.2217/fnl.12.54 · Cited by 49
Kuboyama, T., Hirotsu, K., Arai, T., Yamasaki, H., & Tohda, C. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00805 · Cited by 42
“This was observed in regions related to memory functions (Barker and Warburton, 2011; Vilberg and Davachi, 2013; Tanimizu et al., 2017).”
Griffin, E. F., Scopel, S. E., Stephen, C. A., Holzhauer, A. C., Vaji, M. A., Tuckey, R. A., Berkowitz, L. A., Caldwell, K. A., & Caldwell, G. A. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.037218 · Cited by 61
“…Hu et al., 2009; Kounnas et al., 1995; Li et al., 2012; Liu et al., 2013b; Naj et al., 2011; Nakagawa et al., 2000; Okoshi et al., 2015; Reinders et al., 2016; Snyder et al., 2005; Takahashi et al., 2002; Treusch et al., 2011; Ulrich, 2015; Wang et al., 2000; Yang et al., 1998; Zhao et al., 2015).”
Src inhibition reduces NR2B surface expression and synaptic plasticity in the amygdala
Sinai, L., Duffy, S. N., & Roder, J. C. (2010) · Learning & Memory · doi:10.1101/lm.1765710 · Cited by 49
“…subject to rapid activity-dependent trafficking between synaptic and extrasynaptic domains (Tovar and Westbrook 2002; Groc et al. 2006; Jeyifous et al. 2009) and that this trafficking is dependent on subunit tyrosine phosphorylation (Goebel et al. 2005; Snyder et al. 2005; Braithwaite et al. 2006).”
BackgroundAbisambra, J. F., Fiorelli, T., Padmanabhan, J., Neame, P., Wefes, I., & Potter, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008556 · Cited by 42
“Indeed Ab production and amyloid production has been shown to reduce cell surface levels of other proteins including the NMDA receptor and the EphB2 receptor, both involved in synaptic plasticity [57,58].”
Role of calcium dysregulation in Alzheimer's disease and its therapeutic implications
Joshi, M., Joshi, S. S., Khambete, M., & Degani, M. S. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14175 · Cited by 41
Cantanelli, P., Sperduti, S., Ciavardelli, D., Stuppia, L., Gatta, V., & Sensi, S. L. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00200 · Cited by 42
Zhang, L., Sui, H., Liang, B., Wang, H., Qu, W., Yu, S., & Jin, Y. H. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.203 · Cited by 46
Naito, Y., Tanabe, Y., Lee, A. K., Hamel, E., & Takahashi, H. (2017) · Scientific Reports · doi:10.1038/srep42548 · Cited by 42
Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
Zhou, Y., Sun, Y., Ma, Q., & Liu, Y. (2018) · Cell Stress · doi:10.15698/cst2018.07.143 · Cited by 53
“Moreover, the binding and activation of A on alpha-7 nAChRs induces endocytosis of NMDARs through the action of protein phosphatase 2B [67].”
Alzheimer’s Disease and Protein Kinases
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_11 · Cited by 47
Majdi, M., Ribeiro‐da‐Silva, A., & Cuello, A. C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05966.x · Cited by 50
“NMDA receptors are promoted to internalize and, consequently, lose functionality in cultured cortical neurons (Snyder et al., 2005).”
Reelin Signaling in Neurodevelopmental Disorders and Neurodegenerative Diseases
Joly‐Amado, A., Kulkarni, N., & Nash, K. R. (2023) · Brain Sciences · doi:10.3390/brainsci13101479 · Cited by 51
Reelin links Apolipoprotein E4, Tau, and Amyloid‐β in Alzheimer’s disease
Yi, L. X., Zeng, L., Wang, Q., Tan, E. K., & Zhou, Z. D. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102339 · Cited by 41
Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates
Wang, M., & Arnsten, A. F. T. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1504-6 · Cited by 41
“effect occurs in association with nic-α7Rs([30]).”
Trafficking and Targeting of NMDA Receptors
Petralia, R. S., Wenthold, R. J., & Al‐Hallaq, R. A. (2008) · Frontiers in neuroscience · doi:10.1201/9781420044157.ch8 · Cited by 49
Lesuis, S. L., Kaplick, P. M., Lucassen, P. J., & Krugers, H. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.023 · Cited by 41
“This is thought to occur through an excessive activation of extra-synaptic NMDA receptors (Li et al., 2011, 2009), and a decrease in the expression of synaptic NMDA receptors (Snyder et al., 2005).”
BackgroundEnhanced Dendritic Inhibition and Impaired NMDAR Activation in a Mouse Model of Down Syndrome
Schulz, J. M., Knoflach, F., Hernandez, M.-C., & Bischofberger, J. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2723-18.2019 · Cited by 41
“Another potential pathway could involve APP, as triplication of APP, also located on human chromosome 21 and mouse chromosome 16, has been suggested to promote increased endocytosis of NMDARs in Ts65Dn mice (Snyder et al., 2005; Netzer et al., 2010).”
Bader Lange, M. L., St. Clair, D., Markesbery, W. R., Studzinski, C. M., Murphy, M. P., & Butterfield, D. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.01.004 · Cited by 40
“…on the avenue of association, oligomers can have a Ca2+-mobilizing effect through direct interaction with membrane receptors (Demuro et al., 2005; Snyder et al., 2005), destabilize membrane structure by increasing its permeability and fluidity (Demuro et al., 2005; Kayed et al., 2004; Muller et…”
BackgroundInsulin Signaling in Sporadic Alzheimer’s Disease
Liao, F., & Xu, H. (2009) · Science Signaling · doi:10.1126/scisignal.274pe36 · Cited by 46
Poppinga, W. J., Muñoz-LLancao, P., González-Billault, C. E., & Schmidt, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12882 · Cited by 44
“Accumulating evidence suggests that Aβ-induced neurotoxicity alters NMDA receptor signalling through the cAMP response element-binding protein (CREB), a transcription involved in learning and memory processes (Snyder et al., 2005).”
Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie · doi:10.1002/ange.200802808 · Cited by 41
Liu, Z., Wang, W., Feng, N., Wang, L., Shi, J., & Wang, X. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.03.009 · Cited by 41
Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models
Xu, J., Hartley, B. J., Kurup, P. K., Phillips, A. W., Topol, A., Xu, M., Ononenyi, C., Foscue, E. P., Ho, S.-M., Baguley, T. D., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.163 · Cited by 42
Self-citationLin, C., & Lane, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00540 · Cited by 44
An update on the toxicity of Aβ in Alzheimer’s disease
Götz, J., Ittner, L. M., Schönrock, N., & Cappai, R. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3016 · Cited by 50
Long-term depression: a cell biological view
Sheng, M., & Ertürk, A. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0138 · Cited by 40
I. Mota, S., L. Ferreira, I., Pereira, C., R. Oliveira, C., & Cristina Rego, A. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455322 · Cited by 40
“It was also demonstrated that A 1-42 modifies NMDAR trafficking and activation, leading to GluN1 and GluN2B endocytosis through dephosphorylation of GluN2B subunit at Tyr1472 [20].”
BackgroundParent, M.-A. L. T., Hottman, D. A., Cheng, S., Zhang, W., McMahon, L. L., Yuan, L., & Li, L. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0051-z · Cited by 40
“bed previously (Snyder et al. 2005).”
InfluentialPerversi, F., Costa, C., Labate, A., Lattanzi, S., Liguori, C., Maschio, M. C. E., Meletti, S., Nobili, L., Operto, F. F., Romigi, A., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1182304 · Cited by 40
Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases
Carles, A., Freyssin, A., Perin-Dureau, F., Rubinstenn, G., & Maurice, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073733 · Cited by 47
Boehm, J. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12251 · Cited by 39
“STEP is a brain-specific tyrosine phosphatase that regulates synaptic plasticity by dephosphorylating different targets, including the Y1472 of the NMDA receptor subunit GluN2B, Fyn kinase and AMPA receptors (Nguyen et al., 2002; Pelkey et al., 2002; Snyder et al., 2005; Zhang et al., 2008).”
Qi, Y., Klyubin, I. V., Harney, S. C., Hu, N., Cullen, W. K., Grant, M. K. O., Steffen, J., Wilson, E. N., Carmo, S. D., Remy, S., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0175-x · Cited by 47
“Aß may also downregulate NMDA receptor function via other high affinity binding sites including α7-nicotinic acetylcholine receptors [40,41] and cellular prion protein [42,43].”
Paspalas, C. D., Perley, C. C., Venkitaramani, D. V., Goebel-Goody, S. M., Zhang, Y., Kurup, P., Mattis, J. H., & Lombroso, P. J. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn203 · Cited by 39
“STEP is a brain-specific tyrosine phosphatase implicated in the regulation of synaptic plasticity (Paul et al. 2003, 2007; Snyder et al. 2005).”
Self-citationThe Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease
Brouillette, J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990498 · Cited by 41
“Previous studies have shown that synaptic loss following treatment with different A preparations on primary cell culture or brain slices was associated with rapid decrease in membrane expression of NMDA receptors [58, 115, 129, 130].”
BackgroundResultXu, J., Litterst, C., Georgakopoulos, A., Zaganas, I., & Robakis, N. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.048728 · Cited by 39
Spine pruning in 5xFAD mice starts on basal dendrites of layer 5 pyramidal neurons
Crowe, S. E., & Ellis-Davies, G. C. R. (2014) · Brain Structure and Function · doi:10.1007/s00429-013-0518-6 · Cited by 39
“The LTP results found in 6-month-old 5xFAD mice were consistent with previous observations of impaired NMDA-dependent LTP in CA1 of transgenic FAD mice (Snyder et al. 2005; Dewachter et al. 2009).”
Strategies for molecular imaging dementia and neurodegenerative diseases
Schaller, B. J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2154 · Cited by 38
“Clinical symptoms of AD result from synaptic dysfunction that may be associated with or precedes neuronal loss, although the underlying mechanisms are unknown (Snyder et al 2005).”
Go, B. S., Barry, S. M., & McGinty, J. F. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.10.002 · Cited by 38
“STEP-mediated dephosphorylation of GluN2B at Y1472 induces endocytosis (Snyder et al., 2005), leading to the inhibition of NMDAR-mediated ERK phosphorylation in cortical neuronal cultures (Braithwaite et al.”
Singh, A., Jones, O. D., Mockett, B. G., Ohline, S. M., & Abraham, W. C. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1492-19.2019 · Cited by 42
“, 2013), other non-TNF mechanisms must be in play, such as internalization of NMDA receptors from the plasma membrane (Snyder et al., 2005).”
Jurcau, A., & Simion, A. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200303121016 · Cited by 38
Rolland, M., Powell, R., Jacquier‐Sarlin, M. R., Boisseau, S., Reynaud-Dulaurier, R., Hernández, J. M., André, L., Borel, E., Buisson, A., & Lanté, F. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2501-19.2020 · Cited by 43
“…studies have described a selective reduction of NMDA receptor function by Abos via a decreased membrane expression of memory-related NMDA receptors (Snyder et al., 2005), even if a direct reduction of NMDA receptor function (Chen and Roche, 2007) without alterations of GluN2A and GluN2B expression…”
Advances on the Understanding of the Origins of Synaptic Pathology in AD
Lacor, P. (2007) · Current Genomics · doi:10.2174/138920207783769530 · Cited by 38
“Using different preparations that are expected to yielded reasonable amount of low molecular weight oligomers, a major loss of postsynaptic density protein, PSD95 [180,264], and synaptic receptors, NMDA-R and AMPA-R [180,265-267], was also described.”
InfluentialNetwork Excitability Dysfunction in Alzheimer's Disease: Insights from In Vitro and In Vivo Models
Santos, S. F., Pierrot, N., & Octave, J. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.3.153 · Cited by 44
Ostapchenko, V. G., Beraldo, F. H., Guimarães, A. L. S., Mishra, S., Guzmán, M. S., Fan, J., Martins, V. R., Prado, V. F., & Prado, M. A. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12296 · Cited by 41
“Among possible targets, NMDA receptors (Snyder et al. 2005; Decker et al. 2010), a7 nicotinic acetylcholine receptors (Wang et al. 2000; Magdesian et al. 2005; Bomfim et al. 2012), the insulin receptor (Xie et al. 2002; De Felice et al. 2009; Zhao et al. 2009; De Felice 2013), and the…”
BackgroundJacobsen, L. K., Picciotto, M. R., Heath, C. J., Mencl, W. E., & Gelernter, J. E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.024 · Cited by 39
Sevoflurane alters the expression of receptors and enzymes involved in A β clearance in rats
LIU, Y., GAO, M., MA, L., ZHANG, L., & PAN, N. (2013) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12098 · Cited by 38
Roselli, F., Livrea, P., & Almeida, O. F. X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023097 · Cited by 37
“of synaptic AMPA and NMDA glutamate receptors [9,10,12,13],”
Musardo, S., & Marcello, E. E. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.06.018 · Cited by 41
“Aβ promotes the activation of the phosphatase STEP (Kurup et al., 2010; Snyder et al., 2005a) that dephosphorylates the Tyr1472 of the GluN2B subunit of NMDA receptors.”
Bidirectional relationships between sleep and amyloid-beta in the hippocampus
Dufort‐Gervais, J., Mongrain, V., & Brouillette, J. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.06.009 · Cited by 43
Müller, M., Jacobi, E., Sakimura, K., Malinow, R., & von Engelhardt, J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0611-4 · Cited by 43
“It has been shown that the GluN2B subunit is involved in the Aβ-mediated synaptic dysfunction and spine loss of cultured neurons [7, 30, 40, 74, 79].”
InfluentialAvenanthramide-C Restores Impaired Plasticity and Cognition in Alzheimer’s Disease Model Mice
Ramasamy, V. S., Samidurai, M., Park, H. J., Wang, M., Park, R. Y., Yu, S. Y., Kang, H. K., Hong, S., Choi, W., Lee, Y., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01707-5 · Cited by 38
Yeung, J. H. Y., Palpagama, T. H., Tate, W. P., Peppercorn, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01427 · Cited by 40
“While current literature indicates Aβ is involved in the downregulation of AMPARs and NMDARs, our results and results from Whitcomb et al. (2015) suggest another role of Aβ in the acute setting.”
BackgroundResultInfluentialAbsence of synaptophysin near cortical neurons containing oligomer Aβ in Alzheimer's disease brain
Ishibashi, K., Tomiyama, T., Nishitsuji, K., Hara, M., & Mori, H. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20952 · Cited by 37
“Ab oligomers are also reported to inhibit long-term potentiation (LTP; Lambert et al., 1998; Chapman et al., 1999; Walsh et al., 2002).”
InfluentialDinamarca, M. C., Colombres, M., Cerpa, W., Bonansco, C., & Inestrosa, N. C. (2008) · Neurodegenerative Diseases · doi:10.1159/000113687 · Cited by 37
Mutant Presenilin 1 Alters Synaptic Transmission in Cultured Hippocampal Neurons
Priller, C., Dewachter, I., Vassallo, N., Paluch, S., Pace, C., Kretzschmar, H. A., Van Leuven, F., & Herms, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m605066200 · Cited by 37
Dendritic trafficking for neuronal growth and plasticity
Ehlers, M. D. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130081 · Cited by 36
Metadata
- Authors
- Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., & Greengard, P.
- Affiliations
- Rockefeller University (US)
- Hospital for Sick Children (CA)
- Yale University (US)
- Cornell University (US)
- Corresponding author
- Snyder, Eric M
- Venue
- Nature Neuroscience
- Published
- 2005-07-17
- Volume
- 8
- Issue
- 8
- Pages
- 1051-1058
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1980750700
- Cited by
- 1,561
- References
- 41
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 54 · 2021: 80 · 2020: 75 · 2019: 52 · 2018: 70 · 2017: 74 · 2016: 78 · 2015: 81 · 2014: 89 · 2013: 91 · 2012: 97
- FWCI
- 50.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (01527, 52711)
- National Institute on Aging (AG09464, P01AG009464)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, NMDA receptor trafficking, receptor internalization, Alzheimer's disease, glutamatergic neurotransmission, synaptic plasticity, gamma-secretase inhibitors, alpha7 nicotinic acetylcholine receptor, calcineurin, synaptic dysfunction, cortical neurons
- MeSH terms
- Alzheimer Disease, Animals, Cell Membrane, Cerebral Cortex, Disease Models, Animal, Electric Conductivity, Endocytosis, Enzyme Activation, Neurons, Nuclear Proteins, Peptide Fragments, Receptors, Nicotinic, Synapses, Signal Transduction, Trans-Activators, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Tyrosine Phosphatases, Calcineurin, Protein Transport, CREB-Binding Protein, Mice, Protein Tyrosine Phosphatases, Non-Receptor, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.